135 related articles for article (PubMed ID: 30565471)
1. Factors Associated With the Improved Survival of Head and Neck Neuroblastomas Compared to Other Body Sites.
Kaufmann MR; Camilon PR; Janz TA; Levi JR
Ann Otol Rhinol Laryngol; 2019 Mar; 128(3):241-248. PubMed ID: 30565471
[TBL] [Abstract][Full Text] [Related]
2. Pediatric Patients with Adrenal Neuroblastoma: A SEER Analysis, 2004-2013.
Chen S; Tang W; Yang R; Hu X; Li Z
Am Surg; 2020 Feb; 86(2):127-133. PubMed ID: 32167055
[TBL] [Abstract][Full Text] [Related]
3. A population-based analysis of clinical features and lymph node dissection in head and neck malignant neurogenic tumors.
Fang X; Wang S; Zhao J; Zhang Y; Zhang J; Li Y; Li X; Tai J; Ni X
BMC Cancer; 2021 May; 21(1):598. PubMed ID: 34030648
[TBL] [Abstract][Full Text] [Related]
4. Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project.
Vo KT; Matthay KK; Neuhaus J; London WB; Hero B; Ambros PF; Nakagawara A; Miniati D; Wheeler K; Pearson AD; Cohn SL; DuBois SG
J Clin Oncol; 2014 Oct; 32(28):3169-76. PubMed ID: 25154816
[TBL] [Abstract][Full Text] [Related]
5. Survival Differences Between Pediatric Head and Neck Versus Body Melanoma in the Surveillance, Epidemiology, and End Results Program.
Shi K; Camilon PR; Roberts JM; Meier JD
Laryngoscope; 2021 Feb; 131(2):E635-E641. PubMed ID: 32364637
[TBL] [Abstract][Full Text] [Related]
6. Long-term prognosis of low-risk neuroblastoma treated by surgery alone: an experience from a single institution of China.
Yao W; Li K; Dong KR; Zheng S; Xiao XM
World J Pediatr; 2019 Apr; 15(2):148-152. PubMed ID: 30446974
[TBL] [Abstract][Full Text] [Related]
7. A prospective study of expectant observation as primary therapy for neuroblastoma in young infants: a Children's Oncology Group study.
Nuchtern JG; London WB; Barnewolt CE; Naranjo A; McGrady PW; Geiger JD; Diller L; Schmidt ML; Maris JM; Cohn SL; Shamberger RC
Ann Surg; 2012 Oct; 256(4):573-80. PubMed ID: 22964741
[TBL] [Abstract][Full Text] [Related]
8. [NEUROBLASTOMA IN PEDIATRIC PATIENTS].
Solovyov AE; Morgun VV; Paholchuk AP
Klin Khir; 2015 Jun; (6):59-61. PubMed ID: 26521471
[TBL] [Abstract][Full Text] [Related]
9. Neuroblastoma in Iran: an experience of 32 years at a referral childrens hospital.
Mehdiabadi GB; Arab E; Rafsanjani KA; Ansari S; Moinzadeh AM
Asian Pac J Cancer Prev; 2013; 14(5):2739-42. PubMed ID: 23803024
[TBL] [Abstract][Full Text] [Related]
10. Survival and Surgical Outcomes for Pediatric Head and Neck Melanoma.
Richards MK; Czechowicz J; Goldin AB; Gow KW; Doski J; Goldfarb M; Nuchtern J; Langer M; Beierle EA; Vasudevan S; Gupta D; Parikh SR
JAMA Otolaryngol Head Neck Surg; 2017 Jan; 143(1):34-40. PubMed ID: 27607058
[TBL] [Abstract][Full Text] [Related]
11. Survival of high-risk pediatric neuroblastoma patients in a developing country.
Easton JC; Gomez S; Asdahl PH; Conner JM; Fynn AB; Ruiz C; Ojha RP
Pediatr Transplant; 2016 Sep; 20(6):825-30. PubMed ID: 27235336
[TBL] [Abstract][Full Text] [Related]
12. Computer-assisted image analysis can aid the prognostication of advanced-stage neuroblastomas.
Mogilner JG; Eldar S; Sabo E; Hassoun M; Attias D; Brodski A; Ben Harush M; Kuten A; Steiner Z; Misselevich I; Bejar J; Ben Yizhak D; Kerner V; Laor R; Boss JH
J Cancer Res Clin Oncol; 2000 May; 126(5):285-90. PubMed ID: 10815764
[TBL] [Abstract][Full Text] [Related]
13. Long-term survival outcomes of pediatric adrenal malignancies: An analysis with the upstaged SEER registry during 2000-2019.
Lv Z; Yu Y; Luo Y; Lin S; Xiang X; Mao X; Cheng S
Front Endocrinol (Lausanne); 2022; 13():977105. PubMed ID: 36171902
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Clinical Features and Outcomes in Patients With Bilateral Versus Unilateral Adrenal Neuroblastoma.
Dinh T; Truong B; Matthay KK; DuBois SG
J Pediatr Hematol Oncol; 2017 Mar; 39(2):108-113. PubMed ID: 27820129
[TBL] [Abstract][Full Text] [Related]
15. Neuroblastoma.
Duckett JW; Koop CE
Urol Clin North Am; 1977 Jun; 4(2):285-95. PubMed ID: 331618
[TBL] [Abstract][Full Text] [Related]
16. Neuroblastoma: report on a 21-year experience.
Massad M; Slim MS; Mansour A; Dabbous I; Firzli S; Issa P
J Pediatr Surg; 1986 May; 21(5):388-91. PubMed ID: 3712188
[TBL] [Abstract][Full Text] [Related]
17. Characteristics and Prognosis of Primary Head and Neck Angiosarcomas: A Surveillance, Epidemiology, and End Results Program (SEER) Analysis of 1250 Cases.
Lee KC; Chuang SK; Philipone EM; Peters SM
Head Neck Pathol; 2019 Sep; 13(3):378-385. PubMed ID: 30357539
[TBL] [Abstract][Full Text] [Related]
18. The importance of adjuvant treatment and primary anatomical site in head and neck basaloid squamous cell carcinoma survival: an analysis of the National Cancer Database.
Gootee J; Patel M; Aurit S; Silberstein P
Clin Transl Oncol; 2020 Dec; 22(12):2264-2274. PubMed ID: 32440914
[TBL] [Abstract][Full Text] [Related]
19. Pediatric head and neck fibrosarcomas: A demographical, treatment, and survival analysis and review of a rare case.
Janz TA; Nagasubramanian R; Wei JL
Int J Pediatr Otorhinolaryngol; 2019 Jan; 116():92-96. PubMed ID: 30554717
[TBL] [Abstract][Full Text] [Related]
20. The who, when, and why of primary adrenal malignancies: Insights into the epidemiology of a rare clinical entity.
Chandrasekar T; Goldberg H; Klaassen Z; Wallis CJD; Woon DTS; Herrera-Caceres JO; Kulkarni GS; Fleshner NE
Cancer; 2019 Apr; 125(7):1050-1059. PubMed ID: 30561782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
